ACCESSING HYPERTHERMIA
TREATMENT IN CHINA OR INDIA
CancerFax navigates international patients to accredited hyperthermia centres in China and India โ from eligibility review to treatment completion and follow-up coordination.
analyticsAt a Glance
- check_circleHyperthermia combined with radiation or chemo is available at specialist centres in Shanghai, Guangzhou, Beijing, and Mumbai
- check_circleCost in China and India is 60โ80% lower than equivalent programmes in Germany or the Netherlands
- check_circleCancerFax reviews your case, identifies the right modality, and coordinates hospital admission and interpreter services
- check_circlePatients typically require 4โ8 weeks in-country for a full hyperthermia course alongside radiation
Why China and India for Hyperthermia?
China has one of the world's largest clinical experiences with hyperthermia โ particularly deep regional and HIPEC โ while India offers cost-effective superficial and HIPEC programmes at leading oncology centres.
โChina's hyperthermia volumes exceed most European programmes combined โ experience that translates directly into better outcomes.โ
China โ Deep Regional and HIPEC Leaders
EHBH Shanghai, Sun Yat-sen University Cancer Centre, and Ruijin Hospital run among Asia's highest-volume deep regional hyperthermia programmes. HIPEC for gastric and colorectal peritoneal disease is a standard offering.
India โ Cost-Effective Superficial and HIPEC
Tata Memorial Hospital Mumbai, AIIMS New Delhi, and Apollo Cancer Centres offer superficial hyperthermia and HIPEC programmes at 70โ80% lower cost than Western equivalents with comparable oncology infrastructure.
The CancerFax Navigation Process
CancerFax manages every step from case review to post-treatment follow-up coordination โ patients and families focus on treatment, not logistics.
- 1
Upload Your Medical Records
Submit your pathology, imaging, treatment history, and current oncologist's recommendation through the CancerFax portal.
- 2
Eligibility and Centre Matching
CancerFax's clinical team reviews your case, confirms hyperthermia indication (modality, tumour type, prior treatment), and identifies the most appropriate centre.
- 3
Hospital Coordination
CancerFax liaises directly with the treating centre โ scheduling consultation, confirming treatment slots, and coordinating interpreter and logistics support.
- 4
Travel and Visa Support
CancerFax provides the hospital invitation letter needed for medical visa applications and advises on companion travel, accommodation, and local logistics.
- 5
Treatment and Monitoring
During treatment, CancerFax maintains communication with the hospital team and provides a single point of contact for patients and families.
- 6
Post-Treatment Coordination
CancerFax coordinates discharge summaries, follow-up imaging schedules, and ongoing liaison between the treating centre and the patient's home oncologist.
Key Hyperthermia Centres Accessible Through CancerFax
CancerFax works with accredited hyperthermia centres across China and India that have demonstrated clinical volume and patient outcomes.
| Centre | Location | Modalities | Strength |
|---|---|---|---|
| EHBH (Eastern Hepatobiliary Surgery Hospital) | Shanghai, China | Deep regional, HIPEC | Largest liver cancer centre in Asia โ HIPEC for liver and peritoneal disease |
| Sun Yat-sen University Cancer Centre (SYSUCC) | Guangzhou, China | Deep regional, superficial | Nasopharyngeal carcinoma and cervical cancer hyperthermia expertise |
| Ruijin Hospital | Shanghai, China | Deep regional, HIPEC | Academic centre โ large haematology and solid tumour programme |
| Tata Memorial Hospital | Mumbai, India | Superficial, HIPEC | India's largest cancer centre โ strong head and neck, cervical, sarcoma programmes |
| AIIMS | New Delhi, India | Superficial, HIPEC | Academic public centre with subsidised costs for appropriate cases |
Cost Comparison: China and India vs Western Programmes
Hyperthermia costs vary significantly by modality and country. The figures below are approximate total treatment episode costs including the hyperthermia sessions alongside radiation or chemotherapy.
- $4,000โ8,000Deep regional course โ ChinaPer hyperthermia course (8โ10 sessions) at leading Chinese centres, excluding radiation.
- $2,500โ5,000Superficial or HIPEC โ IndiaCost at Indian specialist centres including HIPEC procedure at major hospitals.
- $25,000โ40,000Equivalent โ Germany/NetherlandsWestern European hyperthermia programme costs for equivalent treatment episodes.
What CancerFax Provides vs What Patients Arrange Independently
Understanding what CancerFax handles versus what remains the patient's responsibility sets accurate expectations before starting the process.
CancerFax Provides
- Clinical eligibility reviewCancerFax's team assesses whether hyperthermia is indicated for your specific tumour type, stage, and treatment history.
- Centre identification and coordinationMatching patients to the appropriate centre based on modality, disease type, cost, and logistics.
- Interpreter and logistics supportChinese-English or local-language interpreter coordination, accommodation guidance, and local transport advice.
Patient Responsibility
- Treatment costs and hospital paymentsCancerFax facilitates access โ all treatment fees are paid directly to the hospital by the patient.
- Travel bookings and insuranceFlights, travel insurance, and personal accommodation are arranged and paid by the patient or family.
- Final treatment decisionsAll medical decisions are made between the patient and the treating physician โ CancerFax provides navigation, not medical advice.
Frequently Asked Questions
Common questions from patients planning to access hyperthermia treatment in China or India.
Access and Logistics
How long will I need to stay in China or India for hyperthermia?
A full hyperthermia course alongside radiation typically requires 5โ6 weeks in-country โ 1 week for pre-treatment workup and planning, plus 4โ5 weeks for the combined treatment schedule. HIPEC is a single-procedure admission of 10โ14 days. CancerFax will advise on the expected duration once your case is reviewed.
Do the Chinese centres speak English?
Most leading Chinese oncology centres have English-speaking staff in their international patient departments, but clinical teams typically communicate in Mandarin. CancerFax provides interpreter coordination for all consultations and treatment discussions at centres where language support is needed.
Can I combine hyperthermia with radiation treatment I start at home?
This is usually not practical โ hyperthermia must be delivered within 4 hours of radiation to be effective, and both modalities must be co-located at the treating centre. Patients typically complete the full combined course in-country rather than splitting treatment between countries.
How do I start the CancerFax process?
Contact CancerFax via the website or WhatsApp and upload your most recent imaging, pathology report, and current treatment summary. CancerFax will review your case within 24โ48 hours and provide an initial eligibility assessment and centre recommendation before any commitment is required.
More from the Hyperthermia Therapy Resource Library
Explore the complete hyperthermia resource โ from the main treatment overview to disease-specific evidence and cost guides.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Ready to Explore Hyperthermia Treatment in China or India?
CancerFax reviews your records, confirms hyperthermia eligibility for your tumour type and stage, and connects you with the most appropriate specialist centre โ managing the full logistics from first contact to discharge.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.